Company Information

Number of Employees 80

Cara Therapeutics cares about pain therapy. The clinical-stage biopharmaceutical company focuses on developing and commercializing new chemical products designed to alleviate pain by selectively targeting kappa opioid receptors. Its proprietary class of product candidates targets the body’s peripheral nervous system. In a test with patients with moderate-to-severe pain, they have demonstrated efficacy without inducing many of the undesirable side effects often associated with pain therapeutics. Cara’s most advanced product candidates are KORSUVA (CR845/difelikefalin) injection and Oral KORSUVA (CR845/difelikefalin). Founded in 2004, the company is based in Stamford, Connecticut.

NAICS 2017 Code 325412
D-U-N-S® Number 168720352

Contact Information

Contact Name Derek Chalmers
Title President and CEO
Address 107 Elm St FL 9, Stamford, CT 06902-3834
Phone 1-203-406-3700

Linked Pathways

Clicking on a link below will provide you with a list of associated and presorted occupations for this current company, by their industry term.